Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00726_DB01018_nanopub.RAd5BJsamblMnG64Ui8KiPneCc8SJ024GaHv4gsBMnPlw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00726_DB01018 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00726_DB01018 label "DDI between Trimipramine and Guanfacine - Trimipramine may reduce the antihypertensive effect of the alpha2-agonist, Guanfacine. Trimipramine may also increase the rebound hypertensive effect of Clonidine. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Clonidine if Trimipramine is initiated, discontinued or dose changed. Guanfacine should be withdrawn very gradually to reduce the risk of hypertensive crisis. [drugbank_resource:DB00726_DB01018]" assertion.
- drugbank_resource:DB00726_DB01018 identifier "drugbank_resource:DB00726_DB01018" assertion.
- drugbank_resource:DB00726_DB01018 title "DDI between Trimipramine and Guanfacine - Trimipramine may reduce the antihypertensive effect of the alpha2-agonist, Guanfacine. Trimipramine may also increase the rebound hypertensive effect of Clonidine. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Clonidine if Trimipramine is initiated, discontinued or dose changed. Guanfacine should be withdrawn very gradually to reduce the risk of hypertensive crisis." assertion.
- drugbank:DB00726 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB01018 assertion.
- drugbank:DB01018 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB01018 assertion.